Immune Checkpoint Blockade Combinations As Promising Strategy for Cancer Immunotherapy in Multiple Myeloma Patients

被引：1
|
作者：
Castella, Barbara [1 ]
Foglietta, Myriam [1 ]
Sciancalepore, Patrizia [1 ]
Tripoli, Ezio [1 ]
Boccadoro, Mario [2 ,3 ]
Massaia, Massimo [2 ]
机构：
[1] Univ Turin, Dept Mol Biotecnol & Hlth Sci, Turin, Italy
[2] Hematol U, AOU Citta Salute Sci, Turin, Italy
[3] Univ Torino, Div Hematol, Myeloma Unit, Turin, Italy
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.2059.2059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2059
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy
    Adachi, Keishi
    Tamada, Koji
    CANCER SCIENCE, 2015, 106 (08) : 945 - 950
  • [32] Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy
    Huang, Jumin
    Jiang, Zebo
    Wang, Yuwei
    Fan, Xiaoqing
    Cai, Jun
    Yao, Xiaojun
    Liu, Liang
    Huang, Jun
    He, Jianxing
    Xie, Chun
    Wu, Qibiao
    Cao, Yabing
    Leung, Elaine Lai-Han
    CURRENT OPINION IN PHARMACOLOGY, 2020, 54 : 1 - 10
  • [33] Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy
    Zhao, Peiqi
    Xu, Yuanlin
    Ji, Wei
    Li, Lanfang
    Qiu, Lihua
    Zhou, Shiyong
    Qian, Zhengzi
    Zhang, Huilai
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2022, 17 : 73 - 89
  • [34] Ovarian Cancer Immunotherapy Through Novel Engineered Glyco Immune Checkpoint Blockade
    Bordoloi, Devivasha
    Kulkarni, Abhijeet J.
    Adeniji, Opeyemi S.
    Bhojnagarwala, Pratik
    Parzych, Elizabeth M.
    Zhang, Rugang
    Abdel-Mohsen, Mohamed
    Weiner, David B.
    MOLECULAR THERAPY, 2022, 30 (04) : 154 - 154
  • [35] Targeting Metabolism to Control Immune Responses in Cancer and Improve Checkpoint Blockade Immunotherapy
    Luby, Angele
    Alves-Guerra, Marie-Clotilde
    CANCERS, 2021, 13 (23)
  • [36] COMBINATION IMMUNE CHECKPOINT BLOCKADE PROMISING IN OPERABLE NSCLC
    Cascone, T.
    William, W. N., Jr.
    Weissferdt, A.
    Leung, C. H.
    Lin, H. Y.
    Pataer, A.
    CANCER DISCOVERY, 2021, 11 (05) : 1003 - 1003
  • [37] Combining active immunotherapy with immune checkpoint blockade for the treatment of advanced prostate cancer
    Antonarakis, Emmanuel S.
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (04) : 520 - 521
  • [38] A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
    Flint, Thomas R.
    Jones, James O.
    Ferrer, Miriam
    Colucci, Francesco
    Janowitz, Tobias
    SEMINARS IN ONCOLOGY, 2018, 45 (03) : 170 - 175
  • [39] Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy
    Sun, Shangqin
    Xu, Liwen
    Zhang, Xinxin
    Pang, Lin
    Long, Zhilin
    Deng, Chunyu
    Zhu, Jiali
    Zhou, Shuting
    Wan, Linyun
    Pang, Bo
    Xiao, Yun
    CANCERS, 2021, 13 (07)
  • [40] Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
    Piening, Alexander
    Ebert, Emily
    Khojandi, Niloufar
    Alspach, Elise
    Teague, Ryan M.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345